| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACVR1
|
activin A receptor, type I
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA2
|
annexin A2
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASPN
|
asporin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CALCRL
|
calcitonin receptor-like
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCK
|
cholecystokinin
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CREBBP
|
CREB binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CST3
|
cystatin C
|
|
CTF1
|
cardiotrophin 1
|
|
CTSC
|
cathepsin C
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DHFR
|
dihydrofolate reductase
|
|
DRD2
|
dopamine receptor D2
|
|
E2F1
|
E2F transcription factor 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FAS
|
Fas cell surface death receptor
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
GATA3
|
GATA binding protein 3
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LTC4S
|
leukotriene C4 synthase
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR103A1
|
microRNA 103a-1
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR21
|
microRNA 21
|
|
MIR27B
|
microRNA 27b
|
|
MIR34A
|
microRNA 34a
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies)
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX4
|
NADPH oxidase 4
|
|
NPPB
|
natriuretic peptide B
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
PAX6
|
paired box 6
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PF4
|
platelet factor 4
|
|
PGR
|
progesterone receptor
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
|
PLIN1
|
perilipin 1
|
|
PLXND1
|
plexin D1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRNP
|
prion protein
|
|
PROX1
|
prospero homeobox 1
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PYY
|
peptide YY
|
|
RAD51D
|
RAD51 paralog D
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RD3
|
retinal degeneration 3
|
|
RECQL
|
RecQ helicase-like
|
|
RHOA
|
ras homolog family member A
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SHH
|
sonic hedgehog
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIRT1
|
sirtuin 1
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
THBD
|
thrombomodulin
|
|
TMEM8B
|
transmembrane protein 8B
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VMP1
|
vacuole membrane protein 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
YAP1
|
Yes-associated protein 1
|